Iron hydroxyethyl starch

Drug Profile

Iron hydroxyethyl starch

Alternative Names: Feramyl; Ferric hydroxide hydroxyethyl starch glucoheptonic acid complex; Iron (III) hydroxide hydroxyethyl starch glucoheptonic acid complex; Iron HES complex - SerumWerk Bernburg; Iron-(III)-hydroxyethyl-starch; Iron-hetastarch complex - SerumWerk Bernburg

Latest Information Update: 07 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Serumwerk Bernburg
  • Class Antianaemics; Heavy metals; Iron compounds
  • Mechanism of Action Iron replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Iron deficiency anaemia

Most Recent Events

  • 14 Oct 2016 SerumWerk Bernburg completes a phase-II trial in Iron deficiency anaemia in Denmark (IV) (EudraCT2015-003069-28)
  • 23 Oct 2015 Phase-II clinical trials in Iron deficiency anaemia in Denmark (IV) (EudraCT2015-003069-28)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top